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Introduction: The management of  tuberculosis is an important public Health issue. TB is a 
reemerging disease linked with HIV infections. It is necessary to compare the treatment outcome of  
patients with only Tuberculosis with those with HIV/AIDs co-infection. This study will also provide 
baseline information on treatment outcome on the DOTS eight month regimen and guide decisions in 
review of  the regimen
Objective: To determine the treatment outcome of  the Directly Observed Treatment Short Course 
(DOTS) in patients with tuberculosis (TB) and TB/HIV co – infection.
Design:  A retrospective descriptive study of  records of  DOTS patients from January 2009 to December 
2010 was compiled. Treatment outcome (cured, completed, failure, died, defaulted, transferred out) and 
HIV status were reviewed. 
Results:A total of  575 cases of  tuberculosis were assessed and126(22%) were HIV positive. From the 
total of  293(51%) new smear positive cases,53%(n=155) had only TB and 42%(n=123) had TB/HIV co-
infection. Cure rate for new smear positive TB and TB/HIV co-infection was 83 %(n=129) and 
74%(n=90) respectively.HIV positive cases were more likely to have higher mortality (17% vs 7%). The 
difference in all other outcomes (treatment failure, defaulted, transferred out) were not statistically 
significant.
Conclusion: HIV co-infection resulted in a poorer outcome. Community oriented programmes, early 





INTRODUCTION country was 81 cases per 100,000 populations which 
ranked second in Africa [4].
Tuberculosis is a global health priority and a disease 
that manifests in its pulmonary form in up to 70% of  The Nigerian National Tuberculosis and Leprosy 
cases or as extra pulmonary affecting all parts of  the Control Programme (NTBLCP) were established in 
body [1]. Globally, an estimated seven million new 1988 for effective TB control operating the Directly 
cases occur each year, resulting in 2 – 3 million Observed Therapy (DOT). The goal of  the National 
deaths despite being curable and preventable with TB program is to reduce, the burden of  TB by 2015 
effective treatment regimens and vaccines [2]. in line with the Millennium Development Goals 
Improvement in case identification and compliance (MDGs) and the STOP TB Partnership targets. 
with appropriate treatment remains a major Some of  the targets are to detect at least 70% of  the 
challenge worldwide [2]. estimated infectious (smear-positive) cases and to 
achieve a cure rate of  at least 85% of  the detected 
Nigeria as the most populous country in sub- smear-positive cases [3].
Saharan Africa, with the highest burden of  
tuberculosis in Africa of  an incidence of  311 per 100, Sub-Saharan Africa remains the hardest-hit region 
000 population peryear out of  which 137/100,000 with more than 68% of  people being infected with 
population are smear positive and prevalence of  HIV [5]. An estimated 3.3million Nigerians are 
616/100,000 population. It is placed among the top living with the virus [6,7].The HIV epidemic is one 
four of  the WHO 22 high burden tuberculosis of  the major challenges affecting TB control globally. 
Countries [3].  The estimated mortality rate for the TB is responsible for about 30% of  deaths 
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among HIV infected individuals [8].The increasing sheet for the period.  All the cases of  tuberculosis 
frequency of  tuberculosis and HIV co-infection were counseled and screened for HIV and the 
has had considerable impact on TB control in Sub- result recorded. Screening for HIV status using 
Saharan Africa making the achievement of  the enzyme linked immunosorbent assay (ELISA) was 
85% success rate a challenge. carried out after pretest counseling and positive 
Treatment outcome results can serve as a proxy of  results were confirmed by Western Blot.
the quality of  TB treatment provided by the health 
care system. However, treatment outcome of  Three sputum samples for the Ziehl-Neelsen test 
tuberculosis patients has not been assessed in Abia was produced by the patients of  which two were 
State, southeast Nigeria. Therefore, this study “on the spot” and supervised and the last was 
assesses treatment outcomes of  tuberculosis and produced early the following morning.
HIV-infected tuberculosis cases at the Federal  
Medical Centre Umuahia, in Southeast Nigeria. The definitions of  the treatment outcomes used 
were as follows; Cured: A patient who was smear 
positive at diagnosis, who completed 6 or 8 months 
thSTUDY AREA AND METHODS: and who is smear negative at the end of  6/7  
month of  therapy  and at least one previous 
The Federal Medical Centre Umuahia is the only occasion. Treatment Completed: A patient who 
federal tertiary health facility in Abia State.. It is were smear–positive at diagnosis and completed 
situated in Umuahia the capital of  Abia state. At the treatment but smear result not available at end of  
Federal Medical centre, Umuahia tuberculosis treatment or all smear negative and Extra-
control programme and services are available, this pulmonary who completed treatment. Success: 
includes quality-assured smear microscopy and The sum of  cured and treatment completed 
directly observed treatment short course. The Treatment failure: Any patient who remains or 
thdrugs are supplied free. Voluntary HIV counselling become again smear positive at the end of  5  
and testing services as well as free antiretroviral month or later during Chemotherapy. Died: Any 
treatment (ART) are provided at the ART Unit of  patient who dies for any reason during the course 
the centre. Federal Medical Centre Umuahia was a of  the treatment. Defaulter: Any patient who has 
mission Hospital with name of  Queen Elizabeth failed to come for Dots for 8 consecutive weeks or 
Hospital before it was taken over by the Federal more after the last attendance during the treatment 
Government of  Nigeria. The Hospital has Transferred out: A patient transferred to another 
community Health Department that manages the treatment centre in another State
cases of  tuberculosis. It provided the infrastructure, 
the building, beds and also the human resources The data was collected with Excel sheet and the 
while the drugs and investigating equipments are variables collected were Sex, Age, Pretreatment 
provided by the German- leprosy through  the weight, Treatment Category, Laboratory results 
State Ministry of  Health. It is the only tertiary and treatment outcomes.
Health Facility in Umuahia and the only Federal 
Health Facility in Abia State. The data collected was analyzed with Microsoft 
Excel 2007and Epi-info 6 statistical software, p 
The study was retrospective in nature and involved values < 0.05 were considered significant. Chi 
review of  the medical records of  all pulmonary TB Square was used for the statistical inference.
patients seen between January 1 2009 and 
December 31 2010 in the DOT centre of  the The study procedures were approved by the Ethical 
Federal Medical Centre Umuahia, Abia, Nigeria. Review Committee of  Federal Medical Centre, 
Data was collected from the DOTS treatment U m u a h i a  w i t h  a s s i g n e d  N u m b e r  
register and the Umuahia North Local FMC/QEH/G.596/Vol.4/016
Government Area tuberculosis quarterly summary 
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RESULT: for both TB 100(61%) co infection 63 (56%) p .6. 
Total number of TB patients was 575. Co- Age group 24-35 Tb 52 (32%), Co-infection 
infection 126(22%),Total new smear positive 20(31%) p .005. Weight 38-54 TB 71(44%), Co-
293(51%), TB + only 53% while co-infection + infection 37 (58%) p.09. Category one 124(76%), 
42%, TB negative 31% and Co-infection 38%.   Co-infection 52 (81%) From outside LGAs TB 
Total TB 163 in 2010 co infection 64 more males (56%), Co infection (72%)  Other States TB(9%), 
The treatment outcomes in the smear negative patients and extra-pulmonary  TB 
showed reduction in the treatment completed and higher mortality in patients with 
TB only than co-infection but not significant. However the failure rate was higher in 
co-infection.
Cure rate for New Tb smear positive 83%, co-infection 74%, Mortality rate New TB 
7% and co-infection 17%
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In the re-treatment cases of tuberculosis the treatment outcome showed a lower cure rate in 
the co-infection.  The patients that completed their treatment were higher in co-infection. 
Mortality rate was slightly lower in co- infection than TB only. The failure was higher in co-
infection
 Cure rate  for new smear positive was better in 2010 than 2009 T B only was 81%in 
2009 while in 2010 87% in co-infection 70% in 2009 and 77% in 2010. However there 
was higher death rate in 2010 in both TB only and co-infection. TB only death rate 
was 5% in 2009, 9% in 2010 and Co-infection 13% in 2009 and 20% in 2010.
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Discussion: recommendation by the World Health Organization 
and the Nigerian National target[13]. HIV/TB co-
 The TB/HIV co-infection rate found in this study infection success rate is similar to the result reported 
was similar to the reports by Ige and Oladokun who from the study in India done on HIV/TB co-
obtained a prevalence of  23.2% in a hospital based infection patients where a success rate of  75% was 
study conducted in the southwest of  Nigeria[9] but found [12]. Likewise, a study done in Ibadan 
lower than 38.4% found by Mukhtar in southwestern Nigeria had a success rate of  
northwestern Nigeria[10]. It is also similar to the 74.4%[9].However, this is much better than the 
findings by Fennier et al in Switzerland Europe who result in Kumasi Ghana which only achieved 44% 
had a seroprevalence of  26.3%[11]  but higher than cure rate because of  the problem of  Multi-Drug 
7.2% found by Vijay et al. in South India Asia[12].  Resistance[14]. The studies carried out in northern 
Nigeria still showed lower cure rates than seen in this 
The high HIV sero-prevalence among TB patients study. 
documented in the present study may be attributable Cure rates of  40% and 62.4% were documented in 
to the fact that the study centre serves as the major Kano and Kaduna states Nigeria respectively [10, 15].  
free specialist HIV referral centre for many states in The low cure rates has public health implication, this 
South Eastern and South Southern part of  Nigeria. may lead to Multi drug resistance which will result in 
Likewise, with the screening of  HIV infected the primary MDR-TB. The MDR-TB will lead to use 
patients for TB and TB patients for HIV, there was of  second line drugs which are not readily available 
better detection rate of  co-infected cases. and has serious side effects. The emergence of  
MDR-TB will pose a serious challenge to the control 
The cure rate in HIV negative smear positive TB of  tuberculosis.
cases in this study as shown in fig. 1 is slightly lower 
than WHO recommendation while the success rate The treatment outcomes between HIV negative TB 
as (Table 1) was the same as minimum patients and HIV-positive TB patients were 
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compared in this study. It was found that the cure competing interest. 
rate was reduced and the mortality rate increased in 
TB/HIV co-infection(7% versus 17%) and it was Approval by the Authors: The authors approved 
statistically significant.However the difference in all the publication of  the manuscript.
other outcomes, treatment completed, failure, 
defaultand died were not statistically significant(Fig 
1) . Similarly, in a study done at the Olabisi Onabanjo 
University Teaching Hospital, Sagamu, south 
western Nigeria, The cure rate was significantly 
lower in HIV infected compared with non-HIV 
infected TB patients (60.3% v 80.0%;p = 0.0001). 
Overall mortality was 5.1% which was significantly 
higher in HIV positive compared to HIV negative 
TB patients (15.5% v 3.1%; p = 0.00007). On the 
whole, 17% defaulted treatment and 1.1% failed 
treatment. These were however not significantly 
related to HIV status [16]. 
The study also showed (Fig 4) better cure rate in 3. Federal Ministry of  Health (2006).Department of  
2010 than 2009. The same was observed in Ghana Public Health. National Tuberculosis and Leprosy 
with better outcome in subsequent years [14] this Control Programme (NTBLCP). Workers' Manual 
may be due to improved management of  patients. It 5th ed., pp. 14 -19.
could also be due to early detection, availability of  
drugs and awareness creation through health 4. World Health Organization (2002). Strategic 
Education. There could be more financial support framework to decrease the burden of  TB/HIV. 
especially for HIV which is also used for TB by the WHO/CDC/TB/2002 .296 ;  WHO/HIV-
agencies and Federal Government.  AIDS/2002.2.2002, Geneva: WHO
A Limitation of  the study was the retrospective 5. UNAIDS (2010). Report On The Global AIDS 
nature of  study where some data could not be E p i d e m i c .  
retrieved and this limited the period of  the study and http://www.unaids.org/globalreport/documents/
the extent of  analysis 20101123_GlobalReport_full_en.pdf.
6. UNAIDS (2010). United Nations General 
Conclusion and Recommendation: Mortality Assembly Special Session (UNGASS) Country 
rate was higher in co infected cases and the cure rate P r o g r e s s  
reduced resulting in poor treatment outcomes. ReportNigeria.http://www.unaids.org/en/dataanalysi
s/monitoringcountryprogress/2010progressreportssubAlthough the cure rate improved in 2010 early 
mittedbycountries/nigeria_2010_country_progress_repdetection and prompt treatment especially for co 
ort_en.pdf.infection where the cure rate was much lower and 
death rate was high is paramount. It is therefore 
http://www.healthsystems2020.org/section/where_imperative to reduce the co infection by preventing 
we_work/nigeriaHIV patients being infected with TB. This can be 
achieved with infection control especially among 
HIV patients, intensive searching of  cases of  co- 8.  World Health Organization (2008). Global 
infection with prompt treatment with both anti-TB Tuberculosis Control Surveillance, planning, and 
and retroviral drugs and Isoniazid preventive f i n a n c i n g .  G e n e v a .  W H O  
therapy. (WHO/HTM/TB/2008.393).
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